BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21506550)

  • 1. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging.
    Yuk SH; Oh KS; Cho SH; Lee BS; Kim SY; Kwak BK; Kim K; Kwon IC
    Biomacromolecules; 2011 Jun; 12(6):2335-43. PubMed ID: 21506550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
    Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC
    Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
    Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
    Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
    Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
    Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
    Key J; Dhawan D; Cooper CL; Knapp DW; Kim K; Kwon IC; Choi K; Park K; Decuzzi P; Leary JF
    Int J Nanomedicine; 2016; 11():4141-55. PubMed ID: 27621615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging.
    Li J; Zheng L; Cai H; Sun W; Shen M; Zhang G; Shi X
    Biomaterials; 2013 Nov; 34(33):8382-92. PubMed ID: 23932250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
    Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
    J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-triphosphate nanoparticles for encapsulation of super-paramagnetic iron oxide as an MRI contrast agent.
    Sanjai C; Kothan S; Gonil P; Saesoo S; Sajomsang W
    Carbohydr Polym; 2014 Apr; 104():231-7. PubMed ID: 24607182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
    Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo.
    Lee CM; Jang D; Kim J; Cheong SJ; Kim EM; Jeong MH; Kim SH; Kim DW; Lim ST; Sohn MH; Jeong YY; Jeong HJ
    Bioconjug Chem; 2011 Feb; 22(2):186-92. PubMed ID: 21243999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple PEG conjugation of SPIO via an Au-S bond improves its tumor targeting potency as a novel MR tumor imaging agent.
    Kojima H; Mukai Y; Yoshikawa M; Kamei K; Yoshikawa T; Morita M; Inubushi T; Yamamoto TA; Yoshioka Y; Okada N; Seino S; Nakagawa S
    Bioconjug Chem; 2010 Jun; 21(6):1026-31. PubMed ID: 20446679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
    Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
    Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy.
    Oh KS; Lee H; Kim JY; Koo EJ; Lee EH; Park JH; Kim SY; Kim K; Kwon IC; Yuk SH
    J Control Release; 2013 Jan; 165(1):9-15. PubMed ID: 23103984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile Synthesis of Folic Acid-Modified Iron Oxide Nanoparticles for Targeted MR Imaging in Pulmonary Tumor Xenografts.
    Zhang Z; Hu Y; Yang J; Xu Y; Zhang C; Wang Z; Shi X; Zhang G
    Mol Imaging Biol; 2016 Aug; 18(4):569-78. PubMed ID: 26620721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted in vivo photodynamic therapy with epidermal growth factor receptor-specific peptide linked nanoparticles.
    Narsireddy A; Vijayashree K; Irudayaraj J; Manorama SV; Rao NM
    Int J Pharm; 2014 Aug; 471(1-2):421-9. PubMed ID: 24939618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
    Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
    Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-pool multifunctional nanoparticles formed by temperature-induced phase transition for cancer-targeting therapy and molecular imaging.
    Oh KS; Lee S; Na JH; Kim JY; Kim DE; Kim K; Kwon IC; Yuk SH; Jeong SY
    Int J Pharm; 2012 Nov; 437(1-2):192-202. PubMed ID: 22944301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles.
    Tan YF; Chandrasekharan P; Maity D; Yong CX; Chuang KH; Zhao Y; Wang S; Ding J; Feng SS
    Biomaterials; 2011 Apr; 32(11):2969-78. PubMed ID: 21257200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
    Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
    Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.